Tower Research Capital LLC (TRC) - KEMPHARM INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of KEMPHARM INC
ValueSharesWeighting
Q3 2023$19,897
+58.7%
4,128
+67.9%
0.00%
Q2 2023$12,541
+16847.3%
2,459
-84.7%
0.00%
-100.0%
Q4 2022$74
-99.8%
16,026
+165.3%
0.00%
+200.0%
Q3 2022$38,000
+35.7%
6,041
-3.7%
0.00%0.0%
Q2 2022$28,000
-80.3%
6,274
-77.8%
0.00%0.0%
Q1 2022$142,000
-6.0%
28,243
+62.8%
0.00%
-66.7%
Q4 2021$151,000
+619.0%
17,347
+688.1%
0.00%
+200.0%
Q3 2021$21,000
-12.5%
2,201
+15.5%
0.00%0.0%
Q2 2021$24,000
-96.0%
1,906
-97.1%
0.00%
-90.0%
Q1 2021$597,00064,9850.01%
Other shareholders
KEMPHARM INC shareholders Q4 2023
NameSharesValueWeighting ↓
Nantahala Capital Management 2,308,216$11,125,6010.95%
Retirement Planning Co of New England, Inc. 347,402$1,674,4780.93%
Mystic Asset Management, Inc. 203,283$979,8240.55%
Kovack Advisors, Inc. 124,109$598,2080.08%
Arete Wealth Advisors, LLC 80,729$389,1140.07%
City State Bank 14,224$690.04%
IFG Advisors, LLC 12,900$62,1780.02%
Measured Wealth Private Client Group, LLC 10,000$48,2000.02%
VisionPoint Advisory Group, LLC 6,860$33,0650.01%
OCCUDO QUANTITATIVE STRATEGIES LP 22,615$109,0040.01%
View complete list of KEMPHARM INC shareholders